Harvard Bioscience, Inc. (HBIO)
0.55
-0.02
(-3.68%)
USD |
NASDAQ |
Mar 06, 16:00
0.4947
-0.06
(-10.05%)
After-Hours: 20:00
Harvard Bioscience Cash from Investing (TTM) : -1.73M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Bio-Rad Laboratories, Inc. | -189.70M |
| Bruker Corp. | -196.50M |
| Azenta, Inc. | -129.94M |
| Bionano Genomics, Inc. | -13.76M |
| Avantor, Inc. | -130.50M |